Volume 7, Issue 4 (Winter 2025)
Iran J Health Insur 2025, 7(4): 227-236 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hekmat H, Namazi Shabestari A, Mirzadeh F S. Exploring the Complex Challenges of Heart Failure: Healthcare Costs, Access, and Social Factors in Iran. Iran J Health Insur 2025; 7 (4) :227-236
URL: http://journal.ihio.gov.ir/article-1-346-en.html
URL: http://journal.ihio.gov.ir/article-1-346-en.html
1- Department of Cardiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran ,fatima_mirzadeh@yahoo.com
2- Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Geriatric Medicine, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran ,
Abstract: (374 Views)
Introduction: Heart failure and cardiovascular diseases pose significant health challenges in Iran and beyond, straining healthcare systems and impacting patients' quality of life due to costs and access issues. Understanding the management challenges of these conditions is essential for improving health outcomes.
Methods: This study explores the challenges of heart failure in Iran by analyzing data from various sources, including the Medical Expenditure Panel Survey (MEPS) and the National Health Interview Survey (NHIS). It also assesses the economic burden of cardiovascular diseases using data from the Global Burden of Disease (GBD) 2019, offering a comprehensive overview of heart failure and its impact on healthcare delivery.
Results: Findings indicate that only 31% of patients with heart failure receive adequate access to cardiovascular medications. Both under-supply and over-supply of medications are linked to increased hospitalizations and higher healthcare costs. Financial barriers significantly impact access to care, particularly for low-income patients and those without insurance. Furthermore, demographic differences, such as race and income, complicate these challenges, highlighting the need for targeted interventions.
Conclusion: Effective management of medication supply and reducing financial barriers are crucial for improving health outcomes in heart disease patients. Targeted policies and strategies can enhance access to care, boost medication adherence, and lower healthcare costs. Future research should focus on diverse populations and integrate clinical data to create tailored interventions that address the specific challenges faced by cardiovascular patients, improving care quality and reducing economic burdens.
Methods: This study explores the challenges of heart failure in Iran by analyzing data from various sources, including the Medical Expenditure Panel Survey (MEPS) and the National Health Interview Survey (NHIS). It also assesses the economic burden of cardiovascular diseases using data from the Global Burden of Disease (GBD) 2019, offering a comprehensive overview of heart failure and its impact on healthcare delivery.
Results: Findings indicate that only 31% of patients with heart failure receive adequate access to cardiovascular medications. Both under-supply and over-supply of medications are linked to increased hospitalizations and higher healthcare costs. Financial barriers significantly impact access to care, particularly for low-income patients and those without insurance. Furthermore, demographic differences, such as race and income, complicate these challenges, highlighting the need for targeted interventions.
Conclusion: Effective management of medication supply and reducing financial barriers are crucial for improving health outcomes in heart disease patients. Targeted policies and strategies can enhance access to care, boost medication adherence, and lower healthcare costs. Future research should focus on diverse populations and integrate clinical data to create tailored interventions that address the specific challenges faced by cardiovascular patients, improving care quality and reducing economic burdens.
Type of Study: Review Article |
Subject:
Special
Received: 2025/01/10 | Revised: 2025/05/7 | Accepted: 2025/02/2 | ePublished: 2025/03/17
Received: 2025/01/10 | Revised: 2025/05/7 | Accepted: 2025/02/2 | ePublished: 2025/03/17
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
